Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

ATOS 2.03 +0.11 (5.73%)
price chart
Atossa Genetics: Spotty Track Record And Short On Cash (ATOS)
investors were burned badly in Oct 2013 when Atossa initiated a voluntary recall of the ForeCYTE Breast Aspirator. The stock price dropped from over $5 to 2'sh instantly.
Why gaining sharply? - Atossa Genetics Inc (ATOS), Penn Virginia Corporation ...  Markets Emerging
Intentions Seekers on News: WP GLIMCHER Inc. (NYSE:WPG), Lorillard, Inc ...  eMarketsDaily
Atossa Genetics (ATOS) Stock Declines Today on Heavy Trading Volume
"We rate ATOSSA GENETICS INC (ATOS) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the ...
Know before you invest: Atossa Genetics Inc (NASDAQ:ATOS), American ...  Markets Emerging
Atossa Genetics Inc (NASDAQ:ATOS) All Set To Wear 'The Favorite Breast ...  NYSE Post
Related articles »  
Story That Gives Atossa Genetics, Inc. (NASDAQ:ATOS) A Boost � Report On ...
Atossa Genetics, Inc. (NASDAQ:ATOS)'s shares skyrocketed 48.12% and is now trading at $2.37, soon after a healthcare company that focuses on the development of a suite of laboratory services, medical devices, and therapeutics for breast cancer ...
Atossa Genetics Signs National Distribution Agreement With Thermo Fisher ...
SEATTLE, WA--(Marketwired - Feb 9, 2015) - Atossa Genetics Inc. ( NASDAQ : ATOS ), the Breast Care Company, has signed an agreement with Thermo Fisher Scientific for distribution of Atossa's FullCYTE Breast Aspirator device in the United States through ...
Atossa Genetics (ATOS) Soars on Distribution Deal, Conn's (CONN) Rating ... (registration)
Atossa Genetics Inc. Provides Update on Pharmacogenetics Testing Now ...
SEATTLE, WA, Dec 19, 2014 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, +38.75% today announced that its subsidiary, The National Reference Laboratory for Breast Health, Inc. (the NRLBH), a CLIA-certified laboratory located in Seattle, ...
Related articles »  
Zacks Long Term Rating Update on Atossa Genetics Inc
Atossa Genetics Inc (NASDAQ:ATOS) remains a strong buy in the latest set of rankings. The counter has received an average rating of 1 by 2 analysts.
Henry Schein Medical to Offer Atossa Genetics' FullCYTE Breast Aspirator
Atossa Genetics Inc. (NASDAQ: ATOS), the Breast Care Company, announced today that Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc. (NASDAQ: HSIC), will offer its customers the FullCYTE Breast Aspirator.
Why did Atossa Genetics shares jump 35 percent on Wednesday?
Zacks said Atossa's revenues should grow by 230 percent in the next six years and the company should be profitable in 2019.
Atossa up on heavy volume (ATOS)  Seeking Alpha
Related articles »  
Atossa Genetics Inc. Hires Pieter van der Poel as Vice President of European ...
SEATTLE, WA--(Marketwired - Dec 16, 2014) - Atossa Genetics Inc. ( NASDAQ : ATOS) today announced that it has hired Pieter van der Poel as Vice President of European Commercial Operations effective December 15, 2014.
Related articles »  
Share Price of Atossa Genetics Inc. Rally 17.07%
Shares of Atossa Genetics Inc. (NASDAQ:ATOS) rose by 17.07% in the past week and 64.1% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 17.4% and the outperformance increases to 55.56% for the last 4 weeks.
Closing Bell Reports: Atossa Genetics, Inc. (ATOS), Geron Corporation (GERN ...  WallStreet Scope
Investor's Choice: Atossa Genetics (NASDAQ:ATOS), CBS Corporation (NYSE ...  Property Mentor